NCT03056703View on ClinicalTrials.gov

Bioequivalence of Single Dose Fast Release Aspirin (1000 mg) Tablet Versus Single Dose of Two 500 mg Fast Release Aspirin Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Pain
Interventions
DRUG

Acetylsalicylic acid (Aspirin, BAY1019036)

One Fast Release Tablet containing 1000 mg acetylsalicylic acid

DRUG

Acetylsalicylic acid (Aspirin, BAY1019036)

Two Fast Release Tablets containing 500 mg acetylsalicylic acid each

Trial Locations (1)

07601

Hackensack

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT03056703 - Bioequivalence of Single Dose Fast Release Aspirin (1000 mg) Tablet Versus Single Dose of Two 500 mg Fast Release Aspirin Tablets | Biotech Hunter | Biotech Hunter